摘要
目的探讨糖化血红蛋白和尿微量白蛋白联合检测在2型糖尿病肾病早期诊断中的临床应用价值。方法将2016年1月至12月在本院接受治疗的80例2型糖尿病患者作为分析组对象,以同期在本院进行健康体验的80例体检者作为对照组对象,比较两组间的糖化血红蛋白与尿微量白蛋白指数的差异。结果与对照组体检者比较,分析组2型糖尿病患者糖化血红蛋白(mg/L:11.43±2.34比5.04±2.54)与尿微量白蛋白含量[(11.61±2.31)%比(5.08±1.45)%]均显著升高,差异均有统计学意义(均P<0.05)。结论 2型糖尿病肾病患者糖化血红蛋白与尿微量白蛋白升高,早期检测有助于提早诊断,对治疗疾病和预防疾病的进一步发展有指导意义。
Objective To explore the glycosylated hemoglobin and urine trace albumin combmecl tletectlon in clinical application value for early diagnosis of type 2 diabetic nephropathy. Methods Between January 2016 and December in our hospital, 80 cases of patients with type 2 diabetes were enrolled as observation; 80 cases of medical health in the same period in our hospital were enrolled as a control. The comparison between the two groups of glycosylated hemoglobin and the urine trace albumin index difference was done. Results Compared with control group medical person, group of patients with type 2 diabetes glycated hemoglobin （rag/L： 11.43 ±2.34 vs. 5.04± 2.54） and urine trace albumin content than [（11.61 ±2.31）% vs. （5.08± 1.45）%） were significantly elevated, differences were statistically significant （all P 〈 0.05）. Conclusion Using glycated hemoglobin in type 2 diabetic nephropathy patients with elevated urine trace albumin for early detection can help early diagnosis, treatment and prevention of disease, which may have a guiding significance for the further development.
出处
《实用检验医师杂志》
2017年第2期83-85,共3页
Chinese Journal of Clinical Pathologist
关键词
糖化血红蛋白
尿微量白蛋白
2型糖尿病肾病
早期诊断
Glycosylated hemoglobin
Urine trace albumin
Type 2 diabetic nephropathy
Earlydiagnosis
